Hyperion Partners, LLC Cel Sci Corp Call Options Transaction History
Hyperion Partners, LLC
- $157 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CVM
# of Institutions
14Shares Held
1.69MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY775KShares$5.91 Million0.0% of portfolio
-
Mai Capital Management526KShares$4.02 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ298KShares$2.27 Million0.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL22.4KShares$171,2470.0% of portfolio
-
Raymond James & Associates St Petersburg, FL18.9KShares$144,0390.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $331M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...